celecoxib has been researched along with Inflammatory Breast Neoplasms in 2 studies
Inflammatory Breast Neoplasms: Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Apricoxib exhibited potency equal to celecoxib at inhibition of prostaglandin E2 synthesis in two inflammatory breast cancer cell lines." | 7.77 | Efficient synthesis of apricoxib, CS-706, a selective cyclooxygenase-2 inhibitor, and evaluation of inhibition of prostaglandin E2 production in inflammatory breast cancer cells. ( Bagsby, AL; Freiter, EM; Mandal, PK; McMurray, JS; Robertson, FM, 2011) |
| " Apricoxib exhibited potency equal to celecoxib at inhibition of prostaglandin E2 synthesis in two inflammatory breast cancer cell lines." | 3.77 | Efficient synthesis of apricoxib, CS-706, a selective cyclooxygenase-2 inhibitor, and evaluation of inhibition of prostaglandin E2 production in inflammatory breast cancer cells. ( Bagsby, AL; Freiter, EM; Mandal, PK; McMurray, JS; Robertson, FM, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mandal, PK | 1 |
| Freiter, EM | 1 |
| Bagsby, AL | 1 |
| Robertson, FM | 1 |
| McMurray, JS | 1 |
| Sun, Y | 1 |
| Li, X | 1 |
| Zhang, L | 1 |
| Liu, X | 1 |
| Jiang, B | 1 |
| Long, Z | 1 |
| Jiang, Y | 1 |
2 other studies available for celecoxib and Inflammatory Breast Neoplasms
| Article | Year |
|---|---|
Efficient synthesis of apricoxib, CS-706, a selective cyclooxygenase-2 inhibitor, and evaluation of inhibition of prostaglandin E2 production in inflammatory breast cancer cells.
Topics: Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Dinoprostone; Female; Humans; Inflammatory Breast Neo | 2011 |
Cell Permeable NBD Peptide-Modified Liposomes by Hyaluronic Acid Coating for the Synergistic Targeted Therapy of Metastatic Inflammatory Breast Cancer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Celecoxib; Cell Line, Tumor; Cell Movem | 2019 |